NCT06422208: Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
- State
- Under way
- Phase
- Phase 1
- People
- 12 planned
- Started
- 7 Aug 2024
- Primary completion
- Dec 2028
- Arms
- Autologous midbrain dopamine neurons
- Results
- None posted
- 20 May 2024: Trial registered
- 7 Aug 2024: Trial started